Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 2, 2010, Pages 171-180

  Ferry, T ^a,b,c,d   Uckay I ^a   Vaudaux, P ^a   Francois P ^a   Schrenzel, J ^a   Harbarth, S ^a   Laurent, F ^c,d   Bernard, L ^e   Vandenesch, F ^c,d   Etienne, J ^c,d   Hoffmeyer, P ^a   Lew, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CROIX ROUSSE HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINCOMYCIN; LINEZOLID; OFLOXACIN; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIMICROBIAL THERAPY; ARTHROPLASTY; ARTICLE; BACTERIUM ISOLATE; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; DEVICE INFECTION; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; ORTHOPEDIC EQUIPMENT; OSTEOSYNTHESIS; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SWITZERLAND; TREATMENT FAILURE; VANCOMYCIN;

EID: 77249108264     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0837-y     Document Type: Article

References (34)

1. DP Lew FA Waldvogel 2004 Osteomyelitis Lancet 364 369 379 10.1016/S0140-6736(04)16727-5 1:CAS:528:DC%2BD2cXmtVSktbc%3D 15276398 (Pubitemid 38976521)
2. AF Widmer 2001 New developments in diagnosis and treatment of infection in orthopedic implants Clin Infect Dis 33 Suppl 2 S94 S106 10.1086/321863 11486305
3. W Zimmerli A Trampuz PE Ochsner 2004 Prosthetic-joint infections N Engl J Med 351 1645 1654 10.1056/NEJMra040181 1:CAS:528:DC%2BD2cXos1Whtbo%3D 15483283 (Pubitemid 39350425)
4. AG Gristina 1987 Biomaterial-centered infection: microbial adhesion versus tissue integration Science 237 1588 1595 10.1126/science.3629258 1:CAS:528:DyaL2sXls1WntLw%3D 3629258
5. DJ Kilgus DJ Howe A Strang 2002 Results of periprosthetic hip and knee infections caused by resistant bacteria Clin Orthop Relat Res 404 116 124 10.1097/00003086-200211000-00021 12439249
6. RA Proctor C von Eiff BC Kahl, et al. 2006 Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections Nat Rev Microbiol 4 295 305 10.1038/nrmicro1384 1:CAS:528:DC%2BD28XitlKnur8%3D 16541137
7. DT Tsukayama B Wicklund RB Gustilo 1991 Suppressive antibiotic therapy in chronic prosthetic joint infections Orthopedics 14 841 844 1:STN:280: DyaK38%2FitVCgsw%3D%3D 1923965
8. MG Wilson K Kelley TS Thornhill 1990 Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases J Bone Joint Surg Am 72 878 883 1:STN:280:DyaK3czgslOmuw%3D%3D 2365721
9. EF Berbari AD Hanssen MC Duffy, et al. 1998 Risk factors for prosthetic joint infection: case-control study Clin Infect Dis 27 1247 1254 10.1086/514991 1:STN:280:DyaK1M%2FksVGhtQ%3D%3D 9827278
10. BY Betsch S Eggli KA Siebenrock, et al. 2008 Treatment of joint prosthesis infection in accordance with current recommendations improves outcome Clin Infect Dis 46 1221 1226 10.1086/529436 18444859 (Pubitemid 351589906)
11. JR Lentino 2003 Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists Clin Infect Dis 36 1157 1161 10.1086/374554 12715311 (Pubitemid 36549638)
12. CD Salgado S Dash JR Cantey, et al. 2007 Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections Clin Orthop Relat Res 461 48 53 17534195
13. A Soriano F Marco JA Martínez, et al. 2008 Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 193 200 10.1086/524667 1:CAS:528:DC%2BD1cXhvVClsbk%3D 18171250 (Pubitemid 351269157)
14. T Ferry M Bes O Dauwalder, et al. 2006 Toxin gene content of the Lyon methicillin-resistant Staphylococcus aureus clone compared with that of other pandemic clones J Clin Microbiol 44 2642 2644 10.1128/JCM.00430-06 1:CAS:528:DC%2BD28Xot1aku74%3D 16825403 (Pubitemid 44092450)
15. DC Oliveira A Tomasz H de Lencastre 2002 Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus Lancet Infect Dis 2 180 189 10.1016/S1473-3099(02)00227-X 1:CAS:528:DC%2BD38XisVWntbk%3D 11944188 (Pubitemid 34462453)
16. MM Amaral LR Coelho RP Flores, et al. 2005 The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells J Infect Dis 192 801 810 10.1086/432515 1:CAS:528:DC%2BD2MXhtVentrbK 16088829 (Pubitemid 41193077)
17. ME Charlson P Pompei KL Ales, et al. 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 10.1016/0021-9681(87)90171-8 1:STN:280: DyaL2s7ms1GnsQ%3D%3D 3558716 (Pubitemid 17055592)
18. W Zimmerli PE Ochsner 2003 Management of infection associated with prosthetic joints Infection 31 99 108 10.1007/s15010-002-3079-9 1:STN:280:DC%2BD3s7msVGhuw%3D%3D 12682815 (Pubitemid 36437724)
19. Clinical and Laboratory Standards Institute (CLSI) (2007) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-S17, Wayne, PA
20. P Francois A Huyghe Y Charbonnier, et al. 2005 Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates J Clin Microbiol 43 3346 3355 10.1128/JCM.43.7.3346-3355.2005 1:CAS:528:DC%2BD2MXntlSlsbk%3D 16000459 (Pubitemid 40981347)
21. O Dauwalder G Lina G Durand, et al. 2008 Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007 J Clin Microbiol 46 3454 3458 10.1128/JCM.01050-08 18667599
22. S Jarraud C Mougel J Thioulouse, et al. 2002 Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease Infect Immun 70 631 641 10.1128/IAI.70.2.631-641. 2002 1:CAS:528:DC%2BD38XoslOrtQ%3D%3D 11796592 (Pubitemid 34083822)
23. Y Kondo T Ito XX Ma, et al. 2007 Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions Antimicrob Agents Chemother 51 264 274 10.1128/AAC.00165-06 1:CAS:528:DC%2BD2sXktVartQ%3D%3D 17043114 (Pubitemid 46047716)
24. P François S Harbarth A Huyghe, et al. 2008 Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005 Emerg Infect Dis 14 304 307 10.3201/eid1402.070229 18258126
25. H Sax K Posfay-Barbe S Harbarth, et al. 2006 Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology J Hosp Infect 63 93 100 10.1016/j.jhin.2005.11.016 1:STN:280: DC%2BD283isVKhtw%3D%3D 16542756
26. J Concato AR Feinstein TR Holford 1993 The risk of determining risk with multivariable models Ann Intern Med 118 201 210 1:STN:280:DyaK3s7htFKhsg%3D%3D 8417638
27. PA Moise G Sakoulas A Forrest, et al. 2007 Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia Antimicrob Agents Chemother 51 2582 2586 10.1128/AAC.00939-06 1:CAS:528:DC%2BD2sXnsVajs7w%3D 17452488 (Pubitemid 47047340)
28. JD Knudsen K Fuursted S Raber, et al. 2000 Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection Antimicrob Agents Chemother 44 1247 1254 10.1128/AAC.44.5.1247-1254.2000 1:CAS:528:DC%2BD3cXislKisbk%3D 10770759 (Pubitemid 30228302)
29. WE Peetermans JJ Hoogeterp AM Hazekamp-van Dokkum, et al. 1990 Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection Antimicrob Agents Chemother 34 1869 1874 1:CAS:528:DyaK3cXmtVCnurs%3D 2149812
30. CM Brandt WW Sistrunk MC Duffy, et al. 1997 Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention Clin Infect Dis 24 914 919 1:STN:280:DyaK2s3oslKltg%3D%3D 9142792
31. CE Marculescu EF Berbari AD Hanssen, et al. 2006 Outcome of prosthetic joint infections treated with debridement and retention of components Clin Infect Dis 42 471 478 10.1086/499234 1:STN:280:DC%2BD28%2Fjt1yqtA%3D%3D 16421790 (Pubitemid 43202518)
32. W Zimmerli AF Widmer M Blatter, et al. 1998 Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group JAMA 279 1537 1541 10.1001/jama.279.19.1537 1:CAS:528:DyaK1cXjs1ygurk%3D 9605897 (Pubitemid 28233008)
33. AF Widmer R Frei Z Rajacic, et al. 1990 Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections J Infect Dis 162 96 102 1:CAS:528:DyaK3cXlsVyktLw%3D 2355207
34. M Drancourt A Stein JN Argenson, et al. 1997 Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin J Antimicrob Chemother 39 235 240 10.1093/jac/39.2.235 1:CAS:528:DyaK2sXjtFKktrk%3D 9069545 (Pubitemid 27116419)